In an era of rapid disruption, static data is no longer enough. We bridge the gap between complex market data and actionable strategy through our unique RaaS (Research-as-a-Service) framework. Explore our latest Industry Intelligence Briefings, methodology deep-dives, and expert analysis designed to provide the clarity you need for high-stakes board presentations, acquisition due diligence, and long-term strategic planning. Need specific answers? Commission a bespoke intelligence study tailored to your requirements.
Indian pharmacy market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical condit…
According to new pipeline report analysis - based on the number of projects on the profiles of 90 drug candidates in development, and 2…
Global antirheumatics market is expected to be worth USD 56.88 billion by 2023 as per newly launched report by NAVADHI Market Research. B…
Global antidiabetics market is expected to be worth USD 56.18 billion by 2023 as per newly launched report by NAVADHI Market Research. Ba…
Global oncology market is expected to be worth USD 202.54 billion by 2023 as per newly launched report by NAVADHI Market Research. …
As per the latest data compiled, the top selling pharmaceutical drugs are HUMIRA® (sales USD 19.93 biilion) by AbbVie Inc.,&n…
Based on U.S. pharmaceutical sales of major pharma companies, we have prepared following list of top 10 pharmaceutical companies in United S…
Spinal Muscular Atrophy [SMA] is a rare hereditary neuromuscular disorder caused by Bi-allelic mutation of survival motor neuron gene 1 (SMN…
